• Info
  • Insider Ownership

Insider Trading & Ownership of Bryan Lawlis V

Summary
The estimated net worth of Bryan Lawlis V is at least $3,209,700 dollars as of 22 May 2025. Bryan Lawlis V is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $3.19M. Bryan Lawlis V is the Director of GERON CORP and owns shares of GERON CORP (GERN) stock worth about $15.7K.
Signature
/s/ Scott A. Samuels, Attorney-in-fact for V. Bryan Lawlis
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Bryan Lawlis V and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Bryan Lawlis V has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $3,209,700.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BIOMARIN PHARMACEUTICAL INC ($3,194,033).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Bryan Lawlis V

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BMRN BIOMARIN PHARMACEUTICAL INC Director $3,194,033 23 May 2023
GERN GERON CORP Director $15,667 +$15,667 +100% 21 May 2025
SYRE Aeglea BioTherapeutics, Inc. Director 07 Jun 2022

Insider Transactions Reported by Bryan Lawlis V:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored